{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:10:18Z","timestamp":1792782618425,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Department of Health Research, India","id":[{"id":"https:\/\/ror.org\/00z72fs19","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"DOI":"10.1007\/s00192-026-06923-x","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:07:09Z","timestamp":1791472029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Efficacy and Safety of Nitrofurantoin Versus Fosfomycin for Acute Uncomplicated Lower Urinary Tract Infection: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","author":[{"given":"Dipika","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamidi","family":"Niveditha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj Kundan","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsa","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudheer Kumar","family":"Devana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"6923_CR1","volume-title":"StatPearls","author":"MJ Bono","year":"2026","unstructured":"Bono MJ, Leslie SW. Uncomplicated urinary tract infections. In: StatPearls\u00a9. StatPearls; 2026."},{"issue":"1","key":"6923_CR2","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2021.210","volume":"1","author":"NJ Tinker","year":"2021","unstructured":"Tinker NJ, Foster RA, Webb BJ, Haydoura S, Buckel WR, Stenehjem EA. Interventions to optimize antimicrobial stewardship. Antimicrob Steward Healthc Epidemiol. 2021;1(1):e46.","journal-title":"Antimicrob Steward Healthc Epidemiol."},{"key":"6923_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/IPC.0000000000001473","author":"C-D Kang","year":"2025","unstructured":"Kang C-D, Marsh K, Siegfried J, Decano A, Rick L, Mazo D, et al. Real-world outcomes with multidose fosfomycin compared to nitrofurantoin for lower urinary tract infections due to extended-spectrum \u03b2-lactamase\u2013producing enterobacterales. Infect Dis Clin Pract. 2025. https:\/\/doi.org\/10.1097\/IPC.0000000000001473.","journal-title":"Infect Dis Clin Pract"},{"issue":"6","key":"6923_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106983","volume":"62","author":"T Cai","year":"2023","unstructured":"Cai T, Novelli A, Tascini C, Stefani S. Rediscovering the value of fosfomycin trometamol in the era of antimicrobial resistance: a systematic review and expert opinion. Int J Antimicrob Agents. 2023;62(6):106983.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"6923_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/JU.0000000000004723","volume":"215","author":"AL Ackerman","year":"2025","unstructured":"Ackerman AL, Bradley M, D\u2019Anci KE, Hickling D, Kim SK, Kirkby E. Updates to recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline (2025). J Urol. 2025;215(1):3\u201312.","journal-title":"J Urol"},{"issue":"1","key":"6923_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","volume":"86","author":"J Kranz","year":"2024","unstructured":"Kranz J, Bartoletti R, Bruy\u00e8re F, Cai T, Geerlings S, K\u00f6ves B, et al. European Association of Urology Guidelines on Urological Infections: summary of the 2024 guidelines. Eur Urol. 2024;86(1):27\u201341.","journal-title":"Eur Urol"},{"issue":"9","key":"6923_CR7","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.cmi.2022.03.014","volume":"28","author":"G Sulis","year":"2022","unstructured":"Sulis G, Sayood S, Katukoori S, Bollam N, George I, Yaeger LH, et al. Exposure to World Health Organization\u2019s AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(9):1193\u2013202.","journal-title":"Clin Microbiol Infect"},{"key":"6923_CR8","volume-title":"The WHO AWaRe (access, watch, reserve) antibiotic book","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. The WHO AWaRe (access, watch, reserve) antibiotic book. World Health Organization; 2022."},{"issue":"17","key":"6923_CR9","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1001\/jama.2018.3627","volume":"319","author":"A Huttner","year":"2018","unstructured":"Huttner A, Kowalczyk A, Turjeman A, Babich T, Brossier C, Eliakim-Raz N, et al. Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: a randomized clinical trial. JAMA. 2018;319(17):1781\u20139.","journal-title":"Jama."},{"key":"6923_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041019","author":"A Shafrir","year":"2023","unstructured":"Shafrir A, Oster Y, Shauly-Aharonov M, Strahilevitz J. Real-life comparison of fosfomycin to nitrofurantoin for the treatment of uncomplicated lower urinary tract infection in women. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11041019.","journal-title":"Biomedicines"},{"key":"6923_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biology14080973","author":"A De Cassai","year":"2025","unstructured":"De Cassai A, Dost B, Tulgar S, Boscolo A. Methodological standards for conducting high-quality systematic reviews. Biology (Basel). 2025. https:\/\/doi.org\/10.3390\/biology14080973.","journal-title":"Biology (Basel)"},{"issue":"6","key":"6923_CR12","first-page":"829","volume":"140","author":"CT Bezerra","year":"2022","unstructured":"Bezerra CT, Grande AJ, Galv\u00e3o VK, Santos D, Atallah \u00c1N, Silva V. Assessment of the strength of recommendation and quality of evidence: GRADE checklist. A descriptive study. Sao Paulo Med J. 2022;140(6):829\u201336.","journal-title":"Sao Paulo Med J"},{"issue":"5","key":"6923_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.4236\/ojog.2017.75056","volume":"7","author":"AS Dawood","year":"2017","unstructured":"Dawood AS, Dawood AS, Nagla SA, El-Bakary MA. Fosfomycin therapy for non-complicated lower urinary tract infections during pregnancy: Tanta University experience. Open J Obstet Gynecol. 2017;7(5):532\u201344.","journal-title":"Open J Obstet Gynecol"},{"key":"6923_CR14","unstructured":"Musa MKL, Gabaldon M, Reyes L. A comparison of the efficacy of a single dose fosfomycin trometamol versus a five-day nitrofurantoin regimen in the treatment of urinary tract infection among pregnant patients at FEU-NRMF Medical Center: a single bling randomized controlled trial. FEU-NRMF Med J. 2016;22(2)."},{"issue":"11","key":"6923_CR15","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/S0149-2918(00)86734-X","volume":"21","author":"GE Stein","year":"1999","unstructured":"Stein GE. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther. 1999;21(11):1864\u201372.","journal-title":"Clin Ther"},{"issue":"4","key":"6923_CR16","doi-asserted-by":"publisher","first-page":"626","DOI":"10.21608\/ejhm.2021.150416","volume":"82","author":"SR El-Mehy","year":"2021","unstructured":"El-Mehy SR, Sanad ZF, El-Lakwa H-S. Efficacy and safety of fosfomycin single-dose therapy compared to nitrofurantoin and cephalosporin in pregnant women with lower urinary tract infection: a randomized controlled trial. Egypt J Hosp Med. 2021;82(4):626\u201331.","journal-title":"Egypt J Hosp Med"},{"issue":"6","key":"6923_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/BF01871127","volume":"15","author":"E Van Pienbroek","year":"1993","unstructured":"Van Pienbroek E, Hermans J, Kaptein AA, Mulder JD. Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women. Pharm World Sci. 1993;15(6):257\u201362.","journal-title":"Pharm World Sci"},{"issue":"10","key":"6923_CR18","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.cmi.2022.05.016","volume":"29","author":"IJ Abbott","year":"2023","unstructured":"Abbott IJ, Peel TN, Cairns KA, Stewardson AJ. Antibiotic management of urinary tract infections in the post-antibiotic era: a narrative review highlighting diagnostic and antimicrobial stewardship. Clin Microbiol Infect. 2023;29(10):1254\u201366.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"6923_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P, T\u00e4ngd\u00e9n T, Bitterman R, Bonomo RA, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022;28(4):521\u201347.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"6923_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14010022","volume":"14","author":"D Sgarabotto","year":"2025","unstructured":"Sgarabotto D, Andretta E, Sgarabotto C. Recurrent urinary tract infections (UTIs): a review and proposal for clinicians. Antibiotics (Basel). 2025;14(1):22.","journal-title":"Antibiotics (Basel)"},{"issue":"11","key":"6923_CR21","volume":"2014","author":"R Nieuwlaat","year":"2014","unstructured":"Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;2014(11):Cd000011.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"6923_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1055\/s-0041-1729141","volume":"13","author":"S Sharma","year":"2021","unstructured":"Sharma S, Verma PK, Rawat V, Varshney U, Singh RK. Fosfomycin versus nitrofurantoin for the treatment of lower UTI in outpatients. J Lab Physicians. 2021;13(2):118\u201322.","journal-title":"J Lab Physicians."}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06923-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-026-06923-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-026-06923-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:07:11Z","timestamp":1791472031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-026-06923-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":22,"alternative-id":["6923"],"URL":"https:\/\/doi.org\/10.1007\/s00192-026-06923-x","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"24 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this study.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}